Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Primary care patient interests in joining a planned multi-cancer early detection clinical trial.

Cancer medicine·2024
Same author

COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients.

Journal of the American Board of Family Medicine : JABFM·2024
Same author

Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening.

Journal of personalized medicine·2023
Same author

Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening.

Journal of personalized medicine·2023
Same author

Barbershop-Facilitated Community-to-Clinic Linkage Implementation Program: Rationale and Protocol for a Novel Program to Prevent Hypertension Among Black Men.

American journal of hypertension·2023
Same author

Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities.

JCO oncology practice·2023

相关实验视频

Updated: May 10, 2026

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K

多种癌症早期检测试验:临床实施的属性

Jon O Ebbert1, Ernest T Hawk2, Christopher V Chambers3

  • 1Mayo Clinic, Rochester, MN, USA.

Cancer biomarkers : section A of Disease markers
|April 2, 2025
PubMed
概括
此摘要是机器生成的。

基于血液的多种癌症早期检测 (MCED) 测试为补充现有的单一癌症查提供了一个有希望的方法. 这些测试旨在通过早期识别多种癌症来提高癌症检测率和患者的治疗结果.

关键词:
准确度 准确度 准确度 准确度坚持性 坚持性临床实施 临床实施有效性 有效性.多种癌症的早期检测.

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.4K

相关实验视频

Last Updated: May 10, 2026

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.4K

科学领域:

  • 在瘤学瘤学.
  • 生物技术是生物技术.
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 目前的癌症查指南涵盖了有限的癌症类型,每年缺少超过一半的美国新病例.
  • 现有的单一癌症查方法在准确性,坚持性和有效性方面表现出差异.
  • 技术的进步使得基于血液的多种癌症早期检测 (MCED) 测试成为可能.

研究的目的:

  • 通过开发基于血液的MCED测试来解决未满足的癌症查需求.
  • 为了补充标准护理 (SoC) 查和改善早期癌症检测.
  • 确定MCED测试的核心属性,需要临床数据才能广泛采用.

主要方法:

  • 在MCED测试开发中利用高通量技术和机器学习.
  • 专注于测试性能指标,如灵敏度,特异性,PPV和NPV.
  • 提出临床数据至关重要的核心属性.

主要成果:

  • MCED测试显示了从单次抽血中早期检测多种癌症的潜力.
  • 这些测试可以补充SoC选,改善坚持和可访问性.
  • 发表的数据主要集中在测试性能上,临床实用性研究正在进行中.

结论:

  • 通过早期检测,MCED测试对改善癌症结果具有显著的希望.
  • 需要进一步的临床数据来证明效用,并建立最佳的实施策略.
  • MCED测试需要FDA的上市前批准和强有力的证据,以广泛整合临床实践.